five-year survival estimates were strongly dependent on whether the patients had primary de novo osteogenic sarcomas ( 37 % ) or whether the sarcomas arose secondary to other skeletal conditions ( 7.5 % ) .
C0029463
osteogenic
C1261473
sarcomas